Acquisition of IT-IS International Ltd

Deal in line with strategy, secures key IP for the Company’s rapid-PCR instruments, expands its core capabilities and product offering

Paris, France and Camberley, UK – 15 October 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the acquisition of the entire share capital of IT-IS International Ltd (IT-IS), a profitable diagnostic instrument development and manufacturing company, for an initial cash consideration of £10.1 million. IT-IS is the exclusive manufacturer of Novacyt’s q16 and q32 rapid polymerase chain reaction (PCR) instruments.